Congenica
Congenica Partners With Indian Diagnostics Lab for Genomic Analysis, Reporting
The partnership with Avesthagen subsidiary Avgen Diagnostics seeks to improve sequencing-based diagnostics services in India with rapid NGS analysis.
GenomOncology, Congenica Team up to Develop Precision Oncology Dx Platform
The firms will build on their existing technologies and seek a CE-IVD mark for a new clinical decision support system for individualized cancer therapies.
Congenica Receives CE Mark for Clinical Decision Support Software
With the CE-IVD designation, Congenica expects to apply its genomic data analysis and clinical decision support to the diagnosis of rare genetic disorders.
Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing
University of Glasgow spinout Gabriel Precision Oncology will contribute a bioinformatics pipeline derived from cancer tissue samples to accelerate MDx adoption.
Congenica Raises £13.3M in Series B Add-On
The new funding brings the Series B total to £23.3 million for the British clinical decision support technology developer.